ARTICLE | Emerging Company Profile
Scenic: targeting genetic modifiers to suppress disease drivers
Emerging Company Profile: Amsterdam-based Scenic is developing small molecules against genetic modifiers for metabolic and inflammatory rare diseases, cancer
June 15, 2021 5:38 PM UTC
BCIQ Company Profiles